NCT01979939 · Interventional trial
UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects
Overall registry status Completed
Phase 3
Conditions Hepatitis C
Delaware Valley sites
- Hospital Of The University Of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory